Today's Date: February 8, 2023
NTT and the University of Tokyo Develop World’s First Optical Computing AI Using an Algorithm Inspired by the Human Brain   •   Kay Baltzell-Rathbone's newly released "Communing With Christ" is a thought-provoking collection of devotions that encourage ref   •   CGI's 2022 ESG Report details its progress in building a more sustainable and inclusive world for all   •   Orion Talent Partners with U.S. Department of Labor to Support Military Transitioning Service Members, Spouses   •   THE ELLINIKON, ONE OF THE WORLD'S LARGEST URBAN REGENERATION PROJECTS, BREAKS GROUND ON RIVIERA TOWER, GREECE'S TALLEST BUILDING   •   CAROL'S DAUGHTER ANNOUNCES BORN TO REPAIR (& MADE TO CARE): BREAKTHROUGH RANGE OF PH BALANCING FORMULAS INSTANTLY HELPS REPA   •   Optii announces sponsorship of International Hotel Technology Forum   •   Demand for Breastfeeding Support Drives Growth of Nest Collaborative Telehealth Platform   •   EnPlusOne Biosciences Expands Scientific Advisory Board   •   AmerisourceBergen Releases 2022 ESG Summary Report to Share Progress and Impact on Environmental, Social and Governance Prioriti   •   Guardant Health receives coverage from UnitedHealthcare for Guardant360® CDx blood test as companion diagnostic in advanced   •   Swim Instruction Leader Aqua-Tots Launches New Swim School App   •   Edifecs Tops 2023 Best In KLAS for New CMS Payer Interoperability Category   •   Navisite Announces Inaugural Winners of Steminist Scholarship Program in India Supporting Young Women in STEM   •   Good News: Inflation and Unemployment Lower; Customer Satisfaction Up   •   Lyniate Earns Best in KLAS® Distinction for Integration Engine Category with Overall Scores of 95.7 and 92   •   KIA WINS 2023 VINCENTRIC BEST VALUE IN AMERICA AWARDS FOR 2023 SORENTO PHEV AND RIO   •   Curio Bioscience Launches Industry’s First Unbiased, High-Resolution, Spatial Transcriptomics Solution   •   Strateos Appoints Alexander K. Arrow as Chief Financial Officer and Expands Team   •   Center for Caregiver Advancement Addresses Urgent Need for Caregiver Training Through Career Pathways Program
Bookmark and Share

Simple tool on ICUS app predicts patient benefit from enhanced ultrasound scan

BOSTON , December 06 /Businesswire/ - A simple and innovative tool – the “CEUS Calculator” -- is now available on mobile phones and desktops to help improve echocardiography lab workflows and appropriate utilization of ultrasound enhancing agents (UEAs).

The CEUS Calculator uses three readily-available variables (age, heart rate, and weight) to predict whether an individual patient’s echocardiogram will require administration of a UEA for optimal assessment of left ventricular opacification (LVO).

Echo lab staff may access the CEUS Calculator free of charge on “ICUS Connect,” the new mobile app created by the International Contrast Ultrasound Society (ICUS), and on the ICUS website ( The CEUS Calculator is based on an algorithm developed at Beth Israel Deaconess Medical Center, a primary teaching hospital of Harvard Medical School, and validated at the Mid-America Heart Institute in Kansas City, Missouri.

“In current practice, echo labs generally scan a patient and review image quality prior to deciding whether to place an IV and administer a UEA,” according to Dr. Jordan Strom, an Assistant Professor of Medicine at Harvard Medical School, Director of the Echocardiography Laboratory at Beth Israel Deaconess Medical Center, and a member of the ICUS board of directors. Dr. Strom was instrumental in developing the CEUS Calculator.

“In busy echo labs, delays in IV placement may cause some sonographers to forgo medically appropriate UEA use and withhold patient access to an important, safe and cost-effective tool for improving ultrasound image quality and diagnostic certainty,” Dr. Strom said.

The new CEUS Calculator allows echo lab staff to calculate the probability of needing UEAs for a given patient before the patient presents for a scheduled echocardiogram. Echo lab staff may simply enter the three variables (weight, age and heart rate) into the CEUS Calculator to determine which patients have a sufficient probability (> 15%) of UEA benefit. Those patients may be asked to arrive at the echo lab 15-20 minutes prior to the scheduled echocardiogram for planned IV placement.

UEAs are used worldwide to enhance ultrasound scans of the heart, liver, kidney, breast and other areas of the body. UEAs do not contain dye and create no known risk of kidney damage. In addition, enhanced ultrasound scans are significantly less expensive than CT or MRI, and do not expose patients or hospital staff to ionizing radiation.

“Use of ultrasound enhancing agents often avoids unnecessary downstream testing, lowers overall imaging costs and improves patient care, and we hope the CEUS Calculator removes an unnecessary impediment to medically appropriate use of this valuable and important technology,” Dr. Strom said.


The International Contrast Ultrasound Society (ICUS) is a nonprofit medical society dedicated to advancing the safe and medically appropriate use of contrast enhanced ultrasound (CEUS) to improve patient care globally. Membership in ICUS is free of charge and there is no fee for ICUS CME-accredited educational programs, newsletters or other resources.

To join ICUS and learn more about CEUS, download ICUS Connect and visit the ICUS website (

STORY TAGS: Medical Devices, Health, Apps/Applications, Technology, Cardiology, United States, North America, Massachusetts, Product/Service,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News